The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...

Pfizer faces growth challenges with patent losses and waning COVID sales. Selling an ATM Put option expiring Nov'25 could ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Officials say the Army has reenlisted more than 23 soldiers who were discharged for refusing the COVID-19 vaccine.

Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, ...

PFE stock is likely to be a great pick for value investors, considering its cheap valuation, as well as for income investors ...

You may know 175-year-old pharmaceutical company Pfizer (NYSE: PFE) best for its COVID-19 vaccine, but investors have long ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

The NHS spring booster campaign is offering Covid jab to groups of vulnerable patients across the UK. Around 7.5 million ...

The Kansas Supreme Court is weighing whether to block a sweeping state law that lets workers easily bypass COVID-19 vaccine ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay.

COVID-19 vaccination during pregnancy was not associated with major structural birth defects, according to a study published ...